Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer—the more specific, the better?

The search and optimization for adjuvant medical treatment options beyond the surgical removal of the primary tumor, is of paramount importance to reduce the high risk of recurrence and death in lung cancer patients.